Related Experiment Video
Updated: Aug 15, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Common variants of LRRK2 are not associated with sporadic Parkinson's disease
Saskia Biskup1, Jakob C Mueller, Manu Sharma
1Institute of Human Genetics, GSF National Research Center for Environment and Health, Neuherberg, Germany.
Abstract:
Multiple mutations in the gene for the leucine-rich repeat kinase (LRRK2) cause autosomal dominant late-onset parkinsonism (PARK8). The Gly2019Ser mutation appears to be common in different populations. To investigate whether this novel gene influences the non-Mendelian sporadic form of Parkinson's disease, we genotyped 121 single nucleotide polymorphisms comprehensively covering the entire LRRK2 gene region in a set of 340 Parkinson's disease patients and 680 matched control subjects from Germany. No association could be demonstrated. We have therefore no evidence for the existence of a common variant in LRRK2 that has a strong influence on Parkinson's disease risk.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Lysosomal Hydrolases
Neural Regulation
Principles of Pharmacogenetics: Types of Genetic Variants

